CA2608021A1 - Compositions and methods for skin care - Google Patents

Compositions and methods for skin care Download PDF

Info

Publication number
CA2608021A1
CA2608021A1 CA002608021A CA2608021A CA2608021A1 CA 2608021 A1 CA2608021 A1 CA 2608021A1 CA 002608021 A CA002608021 A CA 002608021A CA 2608021 A CA2608021 A CA 2608021A CA 2608021 A1 CA2608021 A1 CA 2608021A1
Authority
CA
Canada
Prior art keywords
vitamin
nicotinamide
cadpr
skin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002608021A
Other languages
English (en)
French (fr)
Inventor
Avikam Harel
Zeev Even-Chen
Olga Bloch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermipsor Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2608021A1 publication Critical patent/CA2608021A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
CA002608021A 2005-05-10 2006-05-10 Compositions and methods for skin care Abandoned CA2608021A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67932905P 2005-05-10 2005-05-10
US60/679,329 2005-05-10
PCT/IL2006/000552 WO2006120681A2 (en) 2005-05-10 2006-05-10 Compositions and methods for skin care

Publications (1)

Publication Number Publication Date
CA2608021A1 true CA2608021A1 (en) 2006-11-16

Family

ID=37396969

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002608021A Abandoned CA2608021A1 (en) 2005-05-10 2006-05-10 Compositions and methods for skin care

Country Status (7)

Country Link
US (1) US8034788B2 (OSRAM)
EP (1) EP1879449A4 (OSRAM)
JP (1) JP2008540513A (OSRAM)
CN (1) CN101217868A (OSRAM)
AU (1) AU2006245282A1 (OSRAM)
CA (1) CA2608021A1 (OSRAM)
WO (1) WO2006120681A2 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
AU2006245283B2 (en) * 2005-05-10 2012-11-01 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
WO2008131256A1 (en) * 2007-04-19 2008-10-30 Trinity Laboratories Inc. Improved treatments for premature ejaculation in humans
WO2009022338A2 (en) * 2007-08-16 2009-02-19 Saher Hamed Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
FR2925313A1 (fr) * 2007-12-19 2009-06-26 Oreal Utilisation cosmetique de proteines de type plakoglobine
FR2925314B1 (fr) * 2007-12-19 2012-11-23 Oreal Utilisation cosmetique de proteines de type transglutaminase 3
FR2936421B1 (fr) * 2008-09-29 2011-02-11 Bouill Mariya Le Produit de beaute et de soin pour faire disparaitre les rides du visage, empecher leur apparition et maintenir la tonicite de la peau
RU2397770C1 (ru) * 2008-12-30 2010-08-27 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Поливитаминная мазь для смягчения, питания и заживления кожи и способ ее получения
EP2464357B1 (en) 2009-08-14 2019-05-22 Berg LLC Vitamin d3 and analogs thereof for treating alopecia
US20120322776A1 (en) * 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
WO2011087525A1 (en) * 2010-01-17 2011-07-21 The Procter & Gamble Company Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
CN108430449B (zh) * 2016-01-11 2023-01-24 宝洁公司 处理皮肤状况的方法以及用于其的组合物
US20200100997A1 (en) * 2017-02-06 2020-04-02 3Skin As Sunscreen Composition
KR102069088B1 (ko) * 2018-04-02 2020-01-22 양미경 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
BR112021023035A2 (pt) * 2019-05-17 2022-01-25 Univ Pennsylvania Métodos e composições para tratar obesidade e/ou transtornos cutâneos
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN118384058A (zh) * 2024-04-08 2024-07-26 云南贝泰妮生物科技集团股份有限公司 烟酰胺在制备预防和/或治疗皮肤光老化护肤品和药物中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120722A (en) 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
DE3666587D1 (en) 1985-08-02 1989-11-30 Leo Pharm Prod Ltd Novel vitamin d analogues
US4804502A (en) 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4851401A (en) 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
GB9007236D0 (en) 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
ES2093180T3 (es) 1991-07-05 1996-12-16 Duphar Int Res Compuesto de vitamina d, metodo de preparar este compuesto y producto intermedio de dicho metodo.
DE4141746A1 (de) 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
US5237629A (en) * 1992-03-19 1993-08-17 The United States Of America As Represented By The United States Department Of Energy Digitally controlled distributed phase shifter
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
US5747479A (en) 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
DE69704272D1 (de) 1996-05-02 2001-04-19 Duphar Int Res Vitamin d analoga und verfahren zu ihrer herstellung
US5811414A (en) 1997-05-16 1998-09-22 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
US6262041B1 (en) 1998-04-06 2001-07-17 Bertek Pharmaceuticals, Inc. Use of vitamin D analogs to treat conditions related to increased oxidative stress
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
US20010002396A1 (en) * 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
ES2388425T5 (es) 1999-04-23 2020-02-12 Leo Pharma As Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente
FR2801305B1 (fr) 1999-11-24 2002-12-06 Galderma Res & Dev Analogues de la vitamine d
IL133976A (en) 2000-01-11 2006-09-05 Dermipsor Ltd Agents for the treatment of skin disorders
CA2492248A1 (en) 2002-07-11 2004-01-22 Avikam Harel Composition and methods for the treatment of skin disorders

Also Published As

Publication number Publication date
AU2006245282A1 (en) 2006-11-16
EP1879449A4 (en) 2009-12-16
WO2006120681A3 (en) 2007-01-25
CN101217868A (zh) 2008-07-09
WO2006120681A2 (en) 2006-11-16
EP1879449A2 (en) 2008-01-23
US8034788B2 (en) 2011-10-11
JP2008540513A (ja) 2008-11-20
US20080312181A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
US8034788B2 (en) Composition and methods for skin care
DE69927507T2 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
US6352698B1 (en) Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions
EP0907351B2 (de) Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
US6623728B2 (en) Cosmetic skin care compositions and containing gum mastic
RU2562140C2 (ru) Композиция и способ для лечения признаков старения кожи
US20240130980A1 (en) Compositions for treating acne and dermatological conditions
US20160175223A1 (en) Anti-aging compositions comprising bile acid-fatty acid conjugates
JP2004203893A (ja) ベツリン酸を含む化粧品組成物
CA2608023A1 (en) Compositions comprising calcipotriol and nicotinamide for treating hyperproliferative epidermal diseases
EP1000613A2 (en) Composition against the ageing and its use
EP1565189A1 (en) Anti-aging skin care composition and uses thereof
PL196079B1 (pl) Kompozycja kosmetyczna
EP0615435B1 (en) Skin care composition
JP2004517110A (ja) ２区画パッケージにレチノイドとフィトエストロゲンとを含有するスキンケア製品
EP2133066A1 (en) Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols.
US20140037561A1 (en) Composition and methods of enhanced skin cell turnover
IL187237A (en) Preparations containing calcipotriol and nicotinamide for use in skin care
EP1267813A2 (de) Verwendung von protease-inhibitoren in der kosmetik und pharmazie
US20240423897A1 (en) Longevity serum
US20250049686A1 (en) Collagen serum formulations and methods of use thereof
US20250049685A1 (en) Collagen lotion formulations and methods of use thereof
US20240189205A1 (en) Enriched topical cosmetic composition
US20250049684A1 (en) Collagen cream formulations and methods of use thereof
CN119345166A (zh) 紫萁酮促进胶原蛋白和/或弹性蛋白生成的应用

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130510